-
American Journal of Clinical Pathology Feb 2022Small-volume biopsy-fine-needle aspiration biopsy (FNAB) with or without core biopsy-is in increasing use in diagnosis and management of lymphoma patients. Our objective...
OBJECTIVES
Small-volume biopsy-fine-needle aspiration biopsy (FNAB) with or without core biopsy-is in increasing use in diagnosis and management of lymphoma patients. Our objective was to survey the current practice in small-volume biopsy diagnosis of lymphoma, focusing on the interaction among hematopathologists and cytopathologists and the integration of FNAB, core biopsy, and flow cytometry studies at sign-out.
METHODS
This study used a cross-sectional survey design employing the RedCap database distributed via nine pathology professional society email listservs. The survey consisted of 25 multiple-choice questions and several free text fields. In total, 128 pathologists participated.
RESULTS
Most respondents indicated that FNAB specimens in which lymphoma is a diagnostic consideration (FNAB-L) are seen daily or weekly (68/116; 58.6%). However, most institutions have separate hematopathology and cytopathology services (72/116; 62.1%) with inconsistent communication. When communication occurred, respondents were frequently inclined to reconsider their original diagnoses. Barriers identified included lack of communication, inadequate access to diagnostic studies, no formal subspecialty training, and various opinions regarding FNAB in diagnosing lymphoma.
CONCLUSIONS
This survey showed that FNAB-L specimens are common, with a lack of uniformity in how complementary fine-needle aspiration and core biopsy specimens or flow immunophenotyping results are shared across hematopathology and cytopathology services.
Topics: Biopsy, Fine-Needle; Biopsy, Large-Core Needle; Cross-Sectional Studies; Humans; Immunophenotyping; Pathologists
PubMed: 34508545
DOI: 10.1093/ajcp/aqab111 -
Ultraschall in Der Medizin (Stuttgart,... Oct 2015
Topics: Biopsy, Needle; Humans; Paracentesis; Sensitivity and Specificity; Ultrasonography, Interventional
PubMed: 26468770
DOI: 10.1055/s-0035-1553664 -
The Journal of Thoracic and... May 2020
Topics: Autophagy; Biopsy, Needle; Endosonography
PubMed: 31987610
DOI: 10.1016/j.jtcvs.2019.11.058 -
The Pan African Medical Journal 2018Renal needle biopsy (RNB) is the gold standard in the diagnosis of kidney diseases. It is an invasive technique causing several complications, in particular hemorrhagic...
Renal needle biopsy (RNB) is the gold standard in the diagnosis of kidney diseases. It is an invasive technique causing several complications, in particular hemorrhagic events. This study aims to evaluate our RNB practice, to update the current understanding of the technique for percutaneous renal biopsy, to assess complications and to determine the prevalence of kidney diseases diagnosed in our region. We conducted a retrospective study between January 2015 and June 2017. Sixty-nine patients hospitalized in the Division of Nephrology at the University Hospital Mohamed VI Oujda having undergone native kidney biopsy were included in the study. The average age of patients, at the time of RNB, was 38.16 ±13 years [12-77 years], with a sex ratio (M/F) of 0.86. Nephrotic syndrome was the most frequent indication for RNB in all age groups. Glomerular kidney diseases accounted for 81% of kidney diseases, divided as follows: extra-membranous glomerulonephritis in 19% of patients, focal and segmental hyalinosis in 18%, lupus nephritisin in 11%, chronic glomerulonephrites in 11%, membranoproliferative glomerulonephritis in 7%, extracapillary glomerulonephritis in 5% shared equally with renal amyloidosis. Four percent of RNB showed diabetic nephropathy. Histopathological examination revealed acute post-infectious glomerulonephritis, minimal glomerular lesion, immunoglobulin A (IgA) nephropathy, vasculitis, tubulo-interstizial nephropathies as well as thrombotic microangiopathy, with an estimated rate of 2% respectively. Five percent of RNB showed non-glomerular disease. Macroscopic haematuria was the main complication observed in our case series, with a rate of 2.8%. RNB is the gold standard in the diagnosis of renal disease. However, syndromic diagnosis enables clinician to identify the most probable renal disease and to guide any emergency treatment.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Child; Female; Glomerulonephritis; Hematuria; Humans; Kidney Diseases; Male; Middle Aged; Nephrotic Syndrome; Retrospective Studies; Young Adult
PubMed: 30918570
DOI: 10.11604/pamj.2018.31.44.15604 -
Diagnostic and Interventional Imaging 2014Imaging-guided percutaneous biopsies in patients in oncology provide an accurate diagnosis of malignant tumors. Percutaneous biopsy results are improved by correct use...
Imaging-guided percutaneous biopsies in patients in oncology provide an accurate diagnosis of malignant tumors. Percutaneous biopsy results are improved by correct use of sampling procedures. The risks of percutaneous biopsy are low and its complications are generally moderate. These risks can be reduced using aids such as blund tip introducers, hydrodissection and correct patient positioning. The multidisciplinary team meetings dialogue between oncologist, surgeon and radiologist correctly defines the indications in order to improve the treatment strategies.
Topics: Biopsy, Needle; Equipment Design; Humans; Neoplasms
PubMed: 25043316
DOI: 10.1016/j.diii.2014.04.016 -
The Journal of Thoracic and... Jan 2022
Topics: Aortic Valve Stenosis; Biopsy, Needle; Humans; Postoperative Complications
PubMed: 33863493
DOI: 10.1016/j.jtcvs.2021.03.056 -
Archives of Pathology & Laboratory... Mar 2020
Topics: Biopsy, Needle; Humans; Male; Prostate
PubMed: 32101055
DOI: 10.5858/arpa.2019-0558-LE -
Pulmonology 2022Flexible bronchoscopy is a key diagnostic and therapeutic tool. New endoscopes and technologically advanced navigational modalities have been recently introduced on the... (Review)
Review
Flexible bronchoscopy is a key diagnostic and therapeutic tool. New endoscopes and technologically advanced navigational modalities have been recently introduced on the market and in clinical practice, mainly for the diagnosis of mediastinal lymph adenopathies and peripheral lung nodules. Bronchoscopic sampling tools have not changed significantly in the last three decades, with the sole exception of cryobiopsy. We carried out a non-systematic, narrative literature review aimed at summarizing the scientific evidence on the main indications/contraindications, diagnostic yield, and safety of the available bronchoscopic sampling techniques. Performance of bronchoalveolar lavage, bronchial washing, brushing, forceps biopsy, cryobiopsy and needle aspiration techniques are described, focusing on indications and diagnostic accuracy in the work-up of endobronchial lesions, peripheral pulmonary abnormalities, interstitial lung diseases, and/or hilar-mediastinal lymph adenopathies. Main factors affecting the diagnostic yield and the navigational methods are evaluated. Preliminary data on the utility of the newest sampling techniques (i.e., new needles, triple cytology needle brush, core biopsy system, and cautery-assisted transbronchial forceps biopsy) are shown. TAKE HOME MESSAGE: A deep knowledge of bronchoscopic sampling techniques is crucial in the era of technological bronchoscopy for an optimal management of respiratory diseases.
Topics: Humans; Bronchoscopy; Lung Neoplasms; Bronchoalveolar Lavage; Biopsy, Needle; Lymphadenopathy
PubMed: 32624385
DOI: 10.1016/j.pulmoe.2020.06.007 -
Cancer Cytopathology Oct 2017
Topics: Biopsy, Fine-Needle; Biopsy, Large-Core Needle; Breast Neoplasms; Humans
PubMed: 28837269
DOI: 10.1002/cncy.21908 -
Medicine Aug 2021This study aimed to explore clinical significance of core needle biopsy (CNB) in pathological diagnosis of breast neoplasm.Seventy one breast neoplasm samples were...
This study aimed to explore clinical significance of core needle biopsy (CNB) in pathological diagnosis of breast neoplasm.Seventy one breast neoplasm samples were obtained from Tongzhou Maternal and Child Health Hospital of Beijing between the years of 2006 and 2014. Forty five specimens were obtained via CNB and cases offering 26 of them received neoadjuvant chemotherapy. Pathology, histology, and immunohistochemistry results were compared between CNB specimens and excisional biopsy.Upward and downward tendencies could be observed in CNB specimens and excisional biopsy, respectively, in all items. Tumor proportion of CNB tissues was (33 + 2)/45 = 77.78%, when ductal carcinoma in situ detected by both CNB and excisional biopsy was 31/45 = 68.89%, with a consistency of (31 + 3)/45 = 75.56%. Tumor thrombus detected by both CNB and excisional biopsy was 2/45 = 4.44%. Among cases receiving neoadjuvant chemotherapy, CNB and excisional biopsy, in mitotic figure, cytological scoring and histological grading, showed a total change rate of >50% (50%-75%), while changes in duct and cellular heteromorphism were not distinct. Cases showing changes were up to 73.08%, with 8/26 = 30.77% for rise and 11/26 = 42.31% for descent.CNB could be used for preoperative diagnosis of breast neoplasm, and help to determine proper treatment regimen, thus elevating the rate of breast conserving. However, this method still has several limitations, particularly in immunohistochemical tests of human epidermal receptor protein-2. Neoadjuvant chemotherapy may influence the accuracy of CNB diagnosis.
Topics: Adult; Aged; Biopsy, Large-Core Needle; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging
PubMed: 34449464
DOI: 10.1097/MD.0000000000026970